The information provided on this page is for reference only. Please refer to the latest information published by the partner company.
We are the leading cord blood bank that delivers the highest quality service to our clients.
We build maximum shareholder value by engaging all employees to enable the company to achieve its fullest market and medical potential.
Cordlife Group at a glance
Cordlife Group Limited was established to provide a full suite of cord blood and tissue banking services which include the collection, processing and cryopreservation storage of cord blood stem cells and umbilical cord tissue. Since its inception in 2001, our Group has grown rapidly from a fledging start-up company in Singapore into a multi-national corporation.
Expertise and quality you can trust
Our Group’s in-depth knowledge of cord blood banking practices and standards has developed strong capabilities to attain many accreditations and certifications from many quality standard organizations such as the American Association of Blood Banks (AABB), the International Organization for Standardization (ISO) and Ministry of Health, Singapore.
As a further testament of our quality and standard, we are proud to be appointed as the Quality Advisor to Beijing Cord Blood Bank, the first of its kind in the industry.
Our footprint in Asia
Today, Cordlife Group Limited has established state-of-the-art cord blood processing and tissue storage facilities in Singapore, Hong Kong and Mainland China with a network extended to India, Indonesia and the Philippines.
Our group's in-depth knowledge of the business is recognised by many world-class gold standards and government bodies such as the American Association of Blood Banks (AABB), International Organisation for Standardisation (ISO) and Ministry of Health, Singapore. Our stringent quality systems and proven track record have also earned us the appointment as a Quality Advisor to one of the largest cord blood banks in China - Beijing Cord Blood Bank:
Accreditations and Certification attained by Cordlife Group Limited and associates:
- AABB accreditation (Singapore)
- Ministry of Health certification (Singapore)
- Technology Pioneer, World Economic Forum (Switzerland)
- Good Distribution Practice for Medical Devices Certification (Singapore)
- ISO9001:2008 certification (Hong Kong)
- Ministry of Health (DEPKES) certification (Indonesia)
- ISO9001:2008 certification (Indonesia)
- Department of Health registration (the Philippines)
- Drugs Controller General of India certification (India)
- ISO9001:2008 certification (India)
- Beijing Cord Blood Bank (China)
- Guangdong Cord Blood Bank (China)
More than just stem cell banking
Cordlife Group Limited and associates hold patented technologies in immunotherapy and engages in the commercialisation of intellectual properties from research collaborations and government-funded programmes with key institutes in Europe and the United States to drive new and exciting applications with cord blood stem cells. Ground breaking clinical trials using umbilical cord stem cells for wound management and burns, corneal repair, insulin-producing cells and more are also undergoing in collaboration between our key partner in Singapore and renowned institutes worldwide such as Chinese University of Hong Kong, National Cancer Centre Singapore, National University of Singapore and Duke University from the USA, etc. With the combined strengths of stem cell banking and cellular therapy partnerships, we are well positioned in the cellular therapy arena.